.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Deloitte
McKesson
Cantor Fitzgerald
Cerilliant
Boehringer Ingelheim
Federal Trade Commission
Moodys
Teva

Generated: July 23, 2017

DrugPatentWatch Database Preview

UNIRETIC Drug Profile

« Back to Dashboard

What is the patent landscape for Uniretic, and what generic Uniretic alternatives are available?

Uniretic is a drug marketed by Ucb Inc and is included in one NDA.

The generic ingredient in UNIRETIC is hydrochlorothiazide; moexipril hydrochloride. There are thirty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

Summary for Tradename: UNIRETIC

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list23
Clinical Trials: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:UNIRETIC at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 1997DISCNNoNo► Subscribe► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-003Feb 14, 2002DISCNNoNo► Subscribe► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: UNIRETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 19974,743,450► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 19974,344,949► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-003Feb 14, 20024,743,450► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 19974,344,949► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 19974,743,450► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: UNIRETIC

Drugname Dosage Strength RLD Submissiondate
moexipril hydrochloride and hydrochlorothiazideTablets7.5mg/12.5mg 15 mg/25 mg and 15 mg/12.5 mgUniretic1/15/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
Dow
Federal Trade Commission
Harvard Business School
Cerilliant
Novartis
Cipla
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot